Table 3 : Cox regression analysis for progression in 82 patients.

	HR	P-value	95.0% CI
			Lower	Upper
Line of treatment  (BCG vs. docetaxel)	0.584	0. 289	0.216	1.578
Age (≥65 vs. <65)	3.833	0.088	0.821	17.905
Sex (male vs. female)	4.264	0.080	0.889	7.990
Grade (high vs. low)	14.203	0.048*	1.028	196.161
Multiplicity (multiple vs. single)	2.974	0. 071	0.911	9.710
Size (≥3 cm vs. <3 cm)	0.482	0. 203	0.157	1.483